Lv11
36 积分 2024-04-29 加入
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
2小时前
已完结
Z-Drug Use in the First Trimester of Pregnancy and Risk of Congenital Malformations
1个月前
已完结
Longitudinal Plasma Metabolomics Guides Dynamic Risk Assessment and Dietary Modulation for Esophageal Squamous Cell Cancer Chemoimmunotherapy
2个月前
已完结
Warburg Effect Reshapes Tumor Immunogenicity
3个月前
已完结
Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021
3个月前
已完结
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model
3个月前
已完结
VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease
4个月前
已完结
Targeting SIRT2 induces MLH1 deficiency and boosts antitumor immunity in preclinical colorectal cancer models
5个月前
已完结
Mitochondrial glutathione import enables breast cancer metastasis via integrated stress response signaling
8个月前
已完结
IND-Enabling Studies for a TCR-T targeting a pancreatic cancer G12V KRAS mutation
9个月前
已完结
皖公网安备34019202002308
